{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:45:47Z","timestamp":1767861947830,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1124\/jpet.119.261735","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:25:14Z","timestamp":1576542314000},"page":"285-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam"],"prefix":"10.1016","volume":"372","author":[{"given":"Shu-Hui","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-9550","authenticated-orcid":false,"given":"Doodipala Samba","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.261735_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00003495-199855030-00013","article-title":"Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy","volume":"55","author":"Adkins","year":"1998","journal-title":"Drugs"},{"key":"10.1124\/jpet.119.261735_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mol.117.110569","article-title":"GABA type A receptor activation in the allosteric coagonist model framework: relationship between EC50 and basal activity","volume":"93","author":"Akk","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.119.261735_bib4","first-page":"1","article-title":"Synergy, additivism and antagonism in immunosuppression. A critical review","volume":"28","author":"Berenbaum","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/jpet.119.261735_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.119.261735_bib6","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1523\/JNEUROSCI.23-34-10934.2003","article-title":"Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns","volume":"23","author":"Bianchi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1113\/jphysiol.2014.280263","article-title":"Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones","volume":"593","author":"Brown","year":"2015","journal-title":"J Physiol"},{"key":"10.1124\/jpet.119.261735_bib8","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1038\/s41598-018-28754-7","article-title":"Enhanced GABAergic actions resulting from the coapplication of the steroid 3\u03b1-hydroxy-5\u03b1-pregnane-11,20-dione (alfaxalone) with propofol or diazepam","volume":"8","author":"Cao","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.261735_bib9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib10","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1523\/JNEUROSCI.3393-15.2016","article-title":"Zinc selectively blocks neurosteroid-sensitive extrasynaptic \u03b4GABAA receptors in the hippocampus","volume":"36","author":"Carver","year":"2016","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.261735_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.115.229302","article-title":"Neurosteroid structure-activity relationships for functional activation of extrasynaptic \u03b4GABA(A) receptors","volume":"357","author":"Carver","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib13","doi-asserted-by":"crossref","first-page":"14181","DOI":"10.1523\/JNEUROSCI.0596-14.2014","article-title":"Perimenstrual-like hormonal regulation of extrasynaptic \u03b4-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity","volume":"34","author":"Carver","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib14","doi-asserted-by":"crossref","first-page":"e3000157","DOI":"10.1371\/journal.pbio.3000157","article-title":"Multiple functional neurosteroid binding sites on GABAA receptors","volume":"17","author":"Chen","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1124\/jpet.119.261735_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.119.261735_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.117.244673","article-title":"Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: therapeutic insights for epilepsy","volume":"364","author":"Chuang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.117.246660","article-title":"3\u03b2-Methyl-neurosteroid analogs are preferential positive allosteric modulators and direct activators of extrasynaptic \u03b4-subunit \u03b3-aminobutyric acid type A receptors in the hippocampus dentate gyrus subfield","volume":"365","author":"Chuang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2018.11.031","article-title":"Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus","volume":"148","author":"Chuang","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.261735_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0079-6123(07)63014-3","article-title":"Functional regulation of the dentate gyrus by GABA-mediated inhibition","volume":"163","author":"Coulter","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.119.261735_bib20","first-page":"65","article-title":"Felbamate, gabapentin and topiramate as adjuvant antiepileptic drugs in experimental models of epilepsy","volume":"53","author":"Czuczwar","year":"2001","journal-title":"Pol J Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10928-004-8319-4","article-title":"Assessment of drug interactions relevant to pharmacodynamic indirect response models","volume":"31","author":"Earp","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/jpet.119.261735_bib22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1523\/JNEUROSCI.4751-07.2008","article-title":"Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?","volume":"28","author":"Glykys","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib23","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"P&T"},{"key":"10.1124\/jpet.119.261735_bib24","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00213-014-3538-x","article-title":"Characterization of neurosteroid effects on hyperpolarizing current at \u03b14\u03b22\u03b4 GABAA receptors","volume":"231","author":"Gong","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.261735_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib26","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s00213-016-4369-8","article-title":"Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects","volume":"233","author":"Gunter","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.261735_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/epi.12056","article-title":"Research implications of the institute of medicine report, epilepsy across the spectrum: promoting health and understanding","volume":"54","author":"Hesdorffer","year":"2013","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.119.261735_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABA(A) receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.119.261735_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00000542-199902000-00024","article-title":"Effects of temperature and volatile anesthetics on GABA(A) receptors","volume":"90","author":"Jenkins","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.119.261735_bib30","first-page":"5","article-title":"Neurobiology of epileptogenesis in the temporal lobe","volume":"27","author":"Jutila","year":"2002","journal-title":"Adv Tech Stand Neurosurg"},{"key":"10.1124\/jpet.119.261735_bib31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.0013-9580.2004.04504.x","article-title":"Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice","volume":"45","author":"Kaminski","year":"2004","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.119.261735_bib32","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1124\/jpet.119.261735_bib33","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1111\/bph.12861","article-title":"The neurosteroid 5\u03b2-pregnan-3\u03b1-ol-20-one enhances actions of etomidate as a positive allosteric modulator of \u03b11\u03b22\u03b32L GABAA receptors","volume":"171","author":"Li","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-017-9207-8","article-title":"A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome","volume":"9","author":"Ligsay","year":"2017","journal-title":"J Neurodev Disord"},{"key":"10.1124\/jpet.119.261735_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib36","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.119.261735_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00210-008-0305-8","article-title":"Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves","volume":"378","author":"\u0141uszczki","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib38","first-page":"40","article-title":"Isobolographic analysis of interaction between oxcarbazepine and valproate in pentylenetetrazole-induced seizures in mice","volume":"2","author":"\u0141uszczki","year":"2008","journal-title":"J Pre Clin Clin Res"},{"key":"10.1124\/jpet.119.261735_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-004-0867-z","article-title":"Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study","volume":"369","author":"\u0141uszczki","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1471-4159.2009.05982.x","article-title":"Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs","volume":"109","author":"Madsen","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.119.261735_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","article-title":"GABA(A)R plasticity during pregnancy: relevance to postpartum depression","volume":"59","author":"Maguire","year":"2008","journal-title":"Neuron"},{"key":"10.1124\/jpet.119.261735_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nn1469","article-title":"Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety","volume":"8","author":"Maguire","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.119.261735_bib43","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1999.tb02087.x","article-title":"Basic mechanisms of gabitril (tiagabine) and future potential developments","volume":"40","author":"Meldrum","year":"1999","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.119.261735_bib44","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1124\/jpet.119.261735_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2012.00001","article-title":"GABA Potency at GABA(A) receptors found in synaptic and extrasynaptic zones","volume":"6","author":"Mortensen","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/jpet.119.261735_bib46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/mol.105.016683","article-title":"High-affinity, slowly desensitizing GABAA receptors mediate tonic inhibition in hippocampal dentate granule cells","volume":"69","author":"Mtchedlishvili","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib47","doi-asserted-by":"crossref","first-page":"12718","DOI":"10.1523\/JNEUROSCI.0388-13.2013","article-title":"Tyrosine phosphorylation of GABAA receptor \u03b32-subunit regulates tonic and phasic inhibition in the thalamus","volume":"33","author":"Nani","year":"2013","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.119.261735_bib49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0896-6273(00)80382-7","article-title":"Differences in synaptic GABA(A) receptor number underlie variation in GABA mini amplitude","volume":"19","author":"Nusser","year":"1997","journal-title":"Neuron"},{"key":"10.1124\/jpet.119.261735_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.113.203331","article-title":"Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome","volume":"345","author":"Oakley","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.119.261735_bib52","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jnr.23548","article-title":"Effects of \u03b3-Aminobutyric acid transporter 1 inhibition by tiagabine on brain glutamate and \u03b3-Aminobutyric acid metabolism in the anesthetized rat in vivo","volume":"93","author":"Patel","year":"2015","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.119.261735_bib53","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1528-1167.2007.01182.x","article-title":"Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy","volume":"48","author":"Pieribone","year":"2007","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.119.261735_bib54","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1111\/jne.12351","article-title":"Neurosteroidogenesis today: novel targets for neuroactive steroid synthesis and action and their relevance for translational research","volume":"28","author":"Porcu","year":"2016","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/jpet.119.261735_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/jpet.119.261735_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.vh.2017.12.001","article-title":"GABA-A receptors mediate tonic inhibition and neurosteroid sensitivity in the brain","volume":"107","author":"Reddy","year":"2018","journal-title":"Vitam Horm"},{"key":"10.1124\/jpet.119.261735_bib57","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/epi.14693","article-title":"Extrasynaptic \u03b3-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures","volume":"60","author":"Reddy","year":"2019","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.119.261735_bib58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.119.261735_bib59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1523\/JNEUROSCI.4488-10.2011","article-title":"Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors","volume":"31","author":"Reddy","year":"2011","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eplepsyres.2010.01.009","article-title":"Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model","volume":"89","author":"Reddy","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.119.261735_bib61","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","first-page":"984","article-title":"Neurosteroids: endogenous regulators of seizure susceptibility and role in the treatment of epilepsy","author":"Reddy","year":"2012"},{"key":"10.1124\/jpet.119.261735_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/jpet.114.222075","article-title":"Antiseizure activity of midazolam in mice lacking \u03b4-subunit extrasynaptic GABA(A) receptors","volume":"353","author":"Reddy","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0306-4530(02)00064-1","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties","volume":"28","author":"Rupprecht","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/jpet.119.261735_bib64","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1460-9568.2006.04989.x","article-title":"Tonic GABA(A) receptor-mediated currents in human brain","volume":"24","author":"Scimemi","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/mol.118.113464","article-title":"Analysis of GABAA receptor activation by combinations of agonists acting at the same or distinct binding sites","volume":"95","author":"Shin","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/mol.117.109595","article-title":"The actions of drug combinations on the GABAA receptor manifest as curvilinear isoboles of additivity","volume":"92","author":"Shin","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.261735_bib67","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.1523\/JNEUROSCI.0799-18.2018","article-title":"Chemogenetic isolation reveals synaptic contribution of \u03b4 GABAA receptors in mouse dentate granule neurons","volume":"38","author":"Sun","year":"2018","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.119.261735_bib68","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"10.1124\/jpet.119.261735_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.261735_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pharmthera.2006.08.002","article-title":"Interactions between drugs and occupied receptors","volume":"113","author":"Tallarida","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.119.261735_bib71","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2011.03121.x","article-title":"Standards for epidemiologic studies and surveillance of epilepsy","volume":"52","author":"Thurman","year":"2011","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.119.261735_bib72","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0028-3908(02)00126-0","article-title":"GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons","volume":"43","author":"Vicini","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.261735_bib73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2009.06.003","article-title":"Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model","volume":"86","author":"Wojda","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.119.261735_bib74","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.113.203653","article-title":"Estrous cycle regulation of extrasynaptic \u03b4-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis","volume":"346","author":"Wu","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524269263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.261735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:59:19Z","timestamp":1739973559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524269263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0022356524269263"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.261735","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.261735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}